Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China
· Delayed Price · Currency is CNY 13.97
+0.15 (1.09%)
Apr 29, 2026, 3:04 PM CST
Cachet Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,075 | 4,189 | 3,769 | 4,145 | 4,198 | 4,104 | Upgrade
|
| Market Cap Growth | 9.40% | 11.15% | -9.08% | -1.25% | 2.27% | -0.28% | Upgrade
|
| Enterprise Value | 4,965 | 5,826 | 6,389 | 7,913 | 9,077 | 7,930 | Upgrade
|
| Last Close Price | 13.97 | 14.36 | 12.76 | 13.71 | 13.57 | 12.92 | Upgrade
|
| PE Ratio | 36.76 | 37.61 | 23.83 | 16.58 | 14.14 | 11.60 | Upgrade
|
| Forward PE | - | 11.43 | 11.43 | 12.96 | 6.92 | 6.92 | Upgrade
|
| PS Ratio | 0.21 | 0.22 | 0.16 | 0.14 | 0.16 | 0.16 | Upgrade
|
| PB Ratio | 0.69 | 0.71 | 0.63 | 0.68 | 0.71 | 0.73 | Upgrade
|
| P/TBV Ratio | 1.02 | 1.05 | 0.97 | 1.11 | 1.19 | 1.25 | Upgrade
|
| P/FCF Ratio | 2.98 | 3.06 | 22.85 | 2.97 | - | 6.16 | Upgrade
|
| P/OCF Ratio | 2.93 | 3.01 | 20.90 | 2.60 | - | 4.50 | Upgrade
|
| PEG Ratio | - | 1.63 | 1.63 | 6.48 | 0.56 | 0.56 | Upgrade
|
| EV/Sales Ratio | 0.25 | 0.30 | 0.27 | 0.26 | 0.35 | 0.31 | Upgrade
|
| EV/EBITDA Ratio | 10.76 | 14.62 | 10.40 | 9.14 | 9.18 | 7.12 | Upgrade
|
| EV/EBIT Ratio | 13.24 | 15.53 | 11.38 | 10.80 | 10.92 | 8.15 | Upgrade
|
| EV/FCF Ratio | 3.63 | 4.26 | 38.74 | 5.67 | - | 11.90 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.33 | 0.48 | 0.68 | 0.74 | 0.76 | Upgrade
|
| Debt / EBITDA Ratio | 4.18 | 4.18 | 4.17 | 4.40 | 4.13 | 3.65 | Upgrade
|
| Debt / FCF Ratio | 1.41 | 1.41 | 17.38 | 2.95 | - | 6.44 | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | -0.11 | 0.11 | 0.20 | 0.37 | 0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.59 | -1.59 | 1.05 | 1.42 | 2.21 | 1.75 | Upgrade
|
| Net Debt / FCF Ratio | -0.46 | -0.46 | 3.89 | 0.88 | -6.21 | 2.93 | Upgrade
|
| Asset Turnover | 1.46 | 1.46 | 1.54 | 1.78 | 1.67 | 1.76 | Upgrade
|
| Inventory Turnover | 7.05 | 7.05 | 8.46 | 10.69 | 9.89 | 11.19 | Upgrade
|
| Quick Ratio | 1.29 | 1.29 | 1.20 | 1.15 | 1.10 | 1.16 | Upgrade
|
| Current Ratio | 1.75 | 1.75 | 1.64 | 1.44 | 1.44 | 1.47 | Upgrade
|
| Return on Equity (ROE) | 1.71% | 1.71% | 5.24% | 6.27% | 8.09% | 10.96% | Upgrade
|
| Return on Assets (ROA) | 1.75% | 1.75% | 2.25% | 2.72% | 3.30% | 4.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.43% | 2.31% | 4.66% | 6.44% | 7.68% | 9.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 6.30% | 9.20% | 11.70% | 13.50% | 16.50% | Upgrade
|
| Earnings Yield | 2.73% | 2.66% | 4.20% | 6.03% | 7.07% | 8.62% | Upgrade
|
| FCF Yield | 33.60% | 32.69% | 4.38% | 33.68% | -8.38% | 16.23% | Upgrade
|
| Dividend Yield | 0.83% | 0.80% | 1.33% | 1.90% | 2.28% | 2.86% | Upgrade
|
| Payout Ratio | 97.75% | 97.75% | 105.97% | 85.72% | 95.07% | 68.57% | Upgrade
|
| Buyback Yield / Dilution | -0.09% | -0.09% | -0.71% | 0.12% | 0.46% | -0.38% | Upgrade
|
| Total Shareholder Return | 0.74% | 0.71% | 0.62% | 2.02% | 2.74% | 2.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.